Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Vækstaktier.dk: SMS delivers upgrade packages to returning customer in the USA

SMSMEDPress release08.09.2026 klo 13.40

Scandinavian Medical Solutions has sold and delivered a larger order of upgrade packages for several systems to an existing customer in the USA.

The American customer has previously done business with Scandinavian Medical Solutions, and the transaction therefore highlights the strength of the long-term customer relationships the company has built in the American market. The deal was concluded through the company's US entity, Scandinavian Medical Solutions INC., and handled by SMS' Parts & Aftersales department. The recurring purchase likewise reflects the trust that has been built in Scandinavian Medical Solutions' solutions and service, and supports the continued work of developing and expanding customer relationships in the American market.

The transaction reflects a continued demand for upgrades and aftermarket services that can optimize performance and extend the lifetime of existing diagnostic imaging equipment, which is a key focus area for the company's 'Parts & Aftersales' department. This department supports customers throughout the entire lifetime of the equipment and helps ensure continued high usability of existing systems.

The order is in the range of DKK 2.0-3.5 million, and the company has therefore now announced orders totaling DKK 40.0-64.5 million in the current financial year. On 26 August 2026, Scandinavian Medical Solutions lowered its expectations for the 2025/26 financial year, where revenue is now expected to be DKK 155-175 million with a negative EBITDA of DKK 9-13 million.

Contacts
Email: markus@vaekstaktier.dk
Telephone: +45 50 42 99 18

About Us
Disclaimer: Vaekstaktier has a paid IR-partnership with the company mentioned. The content is for informational purposes and is a redistribution of the company’s own communications.

Website: vaekstaktier.dk

Attachments
SMS delivers upgrade packages to returning customer in the USA